Tissue distribution and myelotoxicity of daunomycin in the rat: Rapid bolus injection vs continuous infusion
- 1 July 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (7) , 801-806
- https://doi.org/10.1016/0277-5379(86)90366-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Daunorubicin-DNA complex in acute nonlymphoblastic leukemiaCancer Chemotherapy and Pharmacology, 1982
- Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancerCancer, 1982
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Tumour localization of monoclonal antibody against a rat mammary carcinoma and suppression of tumour growth with adriamycin-antibody conjugatesCancer Immunology, Immunotherapy, 1982
- Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and manCancer Chemotherapy and Pharmacology, 1982
- Distribution of Daunorubicin Intravenously Injected or Intravenously Infused as Free Drug and as a Complex with DNA in RabbitsPharmacology, 1982
- Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexesCancer Chemotherapy and Pharmacology, 1979
- Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: Plasma levels in DBA2 miceCancer Chemotherapy and Pharmacology, 1979
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973